Charles J. Casamento
Charles J. Casamento's purchase track record
Charles J. Casamento has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/9/2024 | RLMD | $33K | -82.8% | -90.3% | +2.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
GRDX Included in 12 Health Care Stocks Moving Thursday. GRDX was among 12 health care stocks that saw movement during Thursday's intraday session. The stock is currently trading near the upper end of its 52‑week range and is above the 70.4 RSI, indicating a high level of buying interest. It has touched its support level of $2.03 nine times, showing a key area to watch.
Transaction History
| RLMD | ▼ Sell | Gift | 13,000 | $0 | 10/22/2024 | View on chart |
| RLMD | ▲ Buy | Open Market | 13,000 | $33K | 9/9/2024 | View on chart |
| GRDX | ▲ Buy | Grant | 19,633 | $0 | 1/2/2024 | View on chart |
| GRDX | ▼ Sell | Open Market | 10 | $4 | 9/15/2023 | View on chart |
| GRDX | ▼ Sell | Open Market | 6,053 | $2K | 8/31/2023 | View on chart |
| GRDX | ▲ Buy | Grant | 84,745 | $0 | 1/3/2023 | View on chart |
| RLMD | ▲ Buy | Option Exercise | 19,800 | $64K | 4/1/2022 | View on chart |
| RLMD | ▼ Sell | Open Market | 3,300 | $96K | 4/1/2022 | View on chart |
| RLMD | ▼ Sell | Open Market | 3,300 | $96K | 4/1/2022 | View on chart |
| RLMD | ▼ Sell | Open Market | 3,300 | $96K | 4/1/2022 | View on chart |
| RLMD | ▼ Sell | Open Market | 3,300 | $96K | 4/1/2022 | View on chart |
| RLMD | ▼ Sell | Open Market | 3,300 | $96K | 4/1/2022 | View on chart |
| RLMD | ▼ Sell | Open Market | 3,300 | $96K | 4/1/2022 | View on chart |
| RLMD | ▲ Buy | Option Exercise | 10,000 | $46K | 9/22/2021 | View on chart |
| RLMD | ▼ Sell | Open Market | 1,900 | $55K | 9/22/2021 | View on chart |
| RLMD | ▼ Sell | Open Market | 3,300 | $96K | 9/22/2021 | View on chart |
| RLMD | ▼ Sell | Open Market | 1,400 | $41K | 9/22/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Relmada Releases Q2 2026 Earnings Call Transcript
Relmada Therapeutics posted the full transcript of its Q2 2026 earnings call. The discussion covered the company’s financial performance for the quarter, updated guidance, and strategic priorities. Investors can review the transcript for details on revenue, expenses, and future outlook. The release provides a comprehensive view of the company’s recent results.
Relmada Releases Q2 2026 Earnings Call Transcript. Relmada Therapeutics posted the full transcript of its Q2 2026 earnings call. The discussion covered the company’s financial performance for the quarter, updated guidance, and strategic priorities. Investors can review the transcript for details on revenue, expenses, and future outlook. The release provides a comprehensive view of the company’s recent results.